News Results
There are 629,544 News Results
Oct 24, 2024
-- Third Quarter 2024 Operating Revenues: $426.8 million, 1.3% increase -- Third Quarter 2024 Operating Income: $42.6 million, 16.0% increase -- Third Quarter 2024 Earnings Per Share: $1.01 per share,...
Oct 25, 2024
-- Third quarter results reflect improved power cost conditions and continued robust demand growth from high-tech and data center customers -- Narrowing 2024 adjusted earnings guidance from $2.98 to $3.18...
Oct 25, 2024
-- Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% -- Net income of $57.8 million; Adjusted EBITDA of $302.5 million -- Diluted GAAP EPS of $0.08;...
Oct 25, 2024
In first dedicated study of a selective IL-13 inhibitor in patients previously treated with dupilumab, the majority of patients had a history of inadequate response to dupilumab
Oct 25, 2024
First-of-its-kind Phase 3b study shows TREMFYA(®) achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement
Oct 26, 2024
-- New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months(1) -- Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope - a key measure of...
Oct 28, 2024
-- Revenue Reached RMB10,461 Million in the Third Quarter, Excluding COVID-19 Commercial Projects, Up 14.6% Year-over-Year -- Revenue Reached RMB27,702 Million for the First Three Quarters, Excluding COVID-19 Commercial Projects,...
Oct 28, 2024
A greater number of patients treated with subcutaneous TREMFYA(®) induction and maintenance achieved clinical and endoscopic remission at 48 weeks in the Phase 3 GRAVITI study versus placebo
Oct 28, 2024
HAYWARD, Calif., Oct. 28, 2024 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results for the third quarter ended September 27, 2024. "UCT's third quarter results...
Oct 28, 2024
CARTHAGE, Mo., Oct. 28, 2024 /PRNewswire/ -- -- 3Q sales of $1.1 billion, a 6% decrease vs 3Q23 -- 3Q EPS of $.33; 3Q adjusted(1) EPS of $.32, a $.04...
